JUDGES SCIENTIFIC PLC

Share Issue/Capital Change • Jan 31, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5817B

Judges Scientific PLC

31 January 2020

Judges Scientific plc

("Judges", the "Company" or the "Group")

Judges Scientific plc (the "Group" or "Judges")

Blocklisting Application and Total Voting Rights

The Group announces that it has today made an application to AIM for the block listing of 100,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares"). These Ordinary Shares will be available to satisfy the future exercises of options over Ordinary Shares under the Company's Approved and Unapproved Share Option Schemes. These shares, when issued, will rank pari passu in all respects with the existing Ordinary Shares and it is expected that admission will occur on 7 February 2020.

Total Voting Rights

As at 3 February 2020 the total issued share capital has increased to 6,246,091 Ordinary Shares. There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,246,091 Ordinary Shares.

The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed. 

For further information please contact:

Judges Scientific
David Cicurel, CEO Brad Ormsby, Group FD	Tel: +44 (0) 20 3829 6970
Shore Capital (Nominated Adviser & Broker)
Stephane Auton Edward Mansfield Sarah Mather	Tel: +44 (0) 20 7408 4090
Liberum (Joint Broker) Bidhi Bhoma Euan Brown Media enquiries: Alma PR (Financial Public Relations)	Tel : +44 (0) 20 3100 2222
Rebecca Sanders-Hewett Sam Modlin	Tel: +44 (0) 20 3865 4219 judges@almapr.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRWPUACGUPUGUG